Article
WNK4 restrains endometrial cancer progression by reprogramming macrophage polarization toward an M1-like phenotype.
Molecular biology reports - 21 Aug 2026
He Jiarong, Zhang Tian, Xiong Menglan, Zhao Jing, Wan Ziqing, Li Guang, Tian Qi, Zhang Pu, Shu Chuqiang
Abstract excerpt
BACKGROUND: Endometrial cancer lacks robust immune-linked biomarkers that can be translated into tractable therapeutic strategies. WNK4, a member of the with-no-lysine (WNK) kinase family, is involved in cancer-relevant signaling pathways; however, its immunological significance in endometrial cancer has yet to be defined. METHODS: Immune deconvolution and gene-immune correlation analyses were performed to relate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
